Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease

NCT05237388 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT05237388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05237388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Janus Kinase-STAT Inhibition to Reduce APOL1 Associated Kidney Disease
Lead sponsor
Duke University
Phase
Phase 2
Overall status
Completed
Start date
April 20, 2023
Completion date
April 3, 2026
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases